Sarcopenia
Conditions
Interventions
Gold Standard:DXA examination:Measurements were performed using the dual-energy X-ray absorptiometry (DXA) scanner in our institution in accordance with the standard operational protocol. Muscle mass-
Index test:Portable body composition analyzer examination:The Z-METRIX® portable body composition analyzer (BioparHom Co.) was utilized for assessment. The device was connected to a computer, and four
Sponsors
Zhongshan Hospital, Fudan University
Eligibility
Sex/Gender
All
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >=60 years old, willing and able to cooperate with portable body composition analyzer, DXA and sarcopenia-related assessments. 2. Willing to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients who are participating in clinical trials of other drugs. 2. Severe cardiovascular disease (NYHA class III-IV) 2) Patients with severe aortic stenosis, previous history of cardiac arrest, installation of pacemaker or internal automatic defibrillator, and repeated angina attacks in the past six months. 3. Suffering from muscle diseases and taking drugs that affect muscle function; Patients with diseases that affect limb movement, such as patients with severe joint disease (including but not limited to osteoarthritis or rheumatoid arthritis, patients undergoing joint replacement), patients with prosthetic limbs. 4. Severe cognitive dysfunction (MMSE<18 points), aphasia, delirium, schizophrenia, bipolar disorder, depression and other mental illnesses. 5. Severe organ dysfunction (such as end-stage renal disease, liver cirrhosis decompensation). 6. Implanted metal instruments in the body. 7. Patients who are allergic to the ingredients in nutritional intervention preparations. 8. Patients who do not agree to participate in the investigation. 9. Other severe acute or chronic diseases, mental illnesses or abnormal laboratory tests, etc., which are judged by the investigator to be inappropriate for the subject to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Limb muscle mass index; | — |
Countries
China
Contacts
Public ContactWang Weixi
Zhongshan Hospital, Fudan University
Outcome results
None listed